For the HER2 positive subtype, the borderline significance of pre-NAT Ki-67 expression was observed in the multivariable analysis for RFS. 4.
← all excerpts
Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy.
1
—
—